Inventor

Robert E. Garfield

Inventor

Friendswood, TX, US

Overview

1995–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 40 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes37%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%

A61NElectrotherapy16%

A61BDiagnosis14%

A61MDevices for introducing media into, or onto, the body5%

C07DHeterocyclic compounds3%

C07CAcyclic or carbocyclic compounds2%

C12NMicroorganisms or enzymes2%

PatentTitleYear

11,058,900Methods and apparatus for treating a cervix with ultrasound energy2021 10,555,955Trimegestone (TMG) for treatment of preterm birth2020 10,449,183Methods for inhibiting preterm labor and uterine contractility disorders and preventing cervical ripening2019 10,328,254Uterine electrical stimulation system and method2019 9,872,983Uterine electrical stimulation system and method2018 9,731,120'Uterine electrical stimulation system and method'2017 9,572,972'Uterine electrical stimulation system and method'2017 9,271,991'Trimegestone (TMG) for treatment of preterm birth'2016 8,972,028'Uterine electrical stimulation system and method'2015 8,606,371'Uterine electrical stimulation system and method'2013 7,456,197'Pyridinium cationic lipids as gene transfer agents'2008 7,048,951'Systems and methods for topical treatment with nitric oxide'2006 6,844,320'Treatment of preeclampsia, toxemia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor'2005 6,816,744'DEVICE AND SYSTEM FOR REMOTE FOR IN-CLINIC TRANS-ABDOMINAL/VAGINAL/CERVICAL ACQUISITION, AND DETECTION, ANALYSIS, AND COMMUNICATION OF MATERNAL UTERINE AND MATERNAL AND FETAL CARDIAC AND FETAL BRAIN ACTIVITY FROM ELECTRICAL SIGNALS'2004 6,613,757'COMBINATION OF PROSTACYCLIN WITH AN ESTROGEN OR PROGESTIN FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROTIC VASCULAR DISEASE INCLUDING PREECLAMPSIA AND FOR THE TREATMENT OF HYPERTENSION, AND FOR HORMONE REPLACEMENT THERAPY'2003 6,356,777'Methods of and apparatus for activating the muscle cells or nerves of the uterus or cervix'2002 6,333,350'Use of nitric oxide donors and/or substrates or nitric oxide inhibitors for regulating cervical dilatation and extensibility'2001 6,103,275'Systems and methods for topical treatment with nitric oxide'2000 6,040,340'Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors'2000 6,028,106'Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents'2000 5,965,529'Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor'1999 5,962,413'Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor'1999 5,958,878'Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors'1999 5,948,762'Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor or a nitric oxide inhibitor'1999 5,906,987'Treatment of male climacteric disorders with nitric oxide synthase substrates and/or donors, in combination with androgens and/or aromatase inhibitors'1999 5,895,783'Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor'1999 5,869,539'Emulsions of perfluoro compounds as solvents for nitric oxide (NO)'1999 5,811,416'Endothelin antagonist and/or endothelin synthase inhibitor in combination with a progestin, an estrogen, a cyclooxygenase inhibitor, or a nitric acid donor or substrate'1998 5,789,442'Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents'1998 5,776,073'Method and apparatus for analyzing uterine electrical activity from surface measurements for obstetrical diagnosis'1998 5,721,278'Ovulation control by regulating nitric oxide levels'1998 5,698,738'N-nitroso-N-substituted hydroxylamines as nitric oxide donors'1997 5,643,944'Ovulation control by regulating nitric oxide levels'1997 5,623,939'Method and apparatus for analyzing uterine electrical activity from surface measurements for obstetrical diagnosis'1997 5,595,970'Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors'1997 5,546,953'Method and apparatus for the recording and analysis of uterine electrical activity from the abdominal surface'1996 5,522,877'Methods for measuring uterine electrical and mechanical activity'1996 5,470,847'Ovulation control by regulating nitric oxide levels with arginine derivatives'1995 5,450,857'Method for the diagnosis of cervical changes'1995 5,397,344'Methods of and apparatus for measuring uterine electrical and mechanical activity'1995

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1995–2005Patents assigned to UNIV TEXAS (22)· patent assignee history

1995–2005Patents assigned to SCHERING AG (16)· patent assignee history

1995–2006Based in Friendswood, TX, US· patent location history

2008Based in Galveston, TX, US· patent location history

2013–2021Patents assigned to DIGNITY HEALTH (10)· patent assignee history

2013–2017Patents assigned to GARFIELD ROBERT E (4)· patent assignee history

2013–2017Patents assigned to CARP HARVEY (3)· patent assignee history

2013–2021Based in Goodyear, AZ, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
UNIV TEXAS	22	1995–2005
SCHERING AG	16	1995–2005
DIGNITY HEALTH	10	2013–2021
GARFIELD ROBERT Eself	4	2013–2017
CARP HARVEY	3	2013–2017

Locations

Location	Patents	Span
Friendswood, Texas, US	29	1995–2006
Goodyear, AZ, US	10	2013–2021
Galveston, Texas, US	1	2008